Claire Mazumdar
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $4.1M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 12SEC | BCAXBicara Therapeutics Inc. | Sell Plan | 10,000362,152 held (−3%) | $27.98 | $280K | -37.5% |
| Jul 14SEC | BCAXBicara Therapeutics Inc. | Sell Plan | 9,972362,180 held (−3%) | $28.42 | $283K | -38.4% |
| Jul 14SEC | BCAXBicara Therapeutics Inc. | Sell Plan | 28362,152 held (−0%) | $29.68 | $831 | -41.0% |
| May 20SEC | BCAXBicara Therapeutics Inc. | Sell Plan | 12,022365,130 held (−3%) | $19.96 | $240K | -12.3% |
| May 20SEC | BCAXBicara Therapeutics Inc. | Sell Plan | 2,978362,152 held (−1%) | $20.35 | $61K | -14.0% |
| Apr 20SEC | BCAXBicara Therapeutics Inc. | Sell Plan | 15,000362,152 held (−4%) | $23.61 | $354K | -25.9% |
| Mar 20SEC | BCAXBicara Therapeutics Inc. | Sell Plan | 6,499339,392 held (−2%) | $18.84 | $122K | -7.1% |
| Mar 20SEC | BCAXBicara Therapeutics Inc. | Sell Plan | 6,905339,392 held (−2%) | $18.78 | $130K | -6.8% |
| Mar 20SEC | BCAXBicara Therapeutics Inc. | Sell Plan | 1,596339,392 held (−0%) | $18.95 | $30K | -7.7% |
| Mar 11SEC | BCAXBicara Therapeutics Inc. | Sell Plan | 36,766339,392 held (−10%) | $19.17 | $705K | -8.7% |
| Mar 6SEC | BCAXBicara Therapeutics Inc. | Sell Plan | 2,631339,392 held (−1%) | $18.73 | $49K | -6.6% |
| Mar 6SEC | BCAXBicara Therapeutics Inc. | Sell Plan | 1,786339,392 held (−1%) | $18.74 | $33K | -6.6% |
| Mar 6SEC | BCAXBicara Therapeutics Inc. | Sell Plan | 3,817339,392 held (−1%) | $18.75 | $72K | -6.7% |
| Nov 25SEC | BCAXBicara Therapeutics Inc. | Sell Plan | 41,163309,892 held (−12%) | $18.86 | $776K | -7.2% |
| Oct 20SEC | BCAXBicara Therapeutics Inc. | Sell Plan | 24,103309,892 held (−7%) | $18.83 | $454K | -7.1% |
| Oct 15SEC | BCAXBicara Therapeutics Inc. | Sell Plan | 11,445309,892 held (−4%) | $18.92 | $217K | -7.5% |
| Oct 15SEC | BCAXBicara Therapeutics Inc. | Sell Plan | 13,289309,892 held (−4%) | $18.84 | $250K | -7.1% |
- Sell
CEO Claire Mazumdar sold $280K of BCAX at $27.98 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Claire Mazumdar sold $283K of BCAX at $28.42 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Claire Mazumdar sold $831 of BCAX at $29.68 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Claire Mazumdar sold $240K of BCAX at $19.96 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Claire Mazumdar sold $61K of BCAX at $20.35 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Claire Mazumdar sold $354K of BCAX at $23.61 — pre-scheduled 10b5-1 plan sale.